Business groups are raising privacy concerns after state regulators requested detailed data on Floridians' prescription drugs, including patients' names and dates of birth and their doctors.

Ed Kaplan, the national health practice leader at Segal, also has concerns about "any willing provider" strategies.

GLP-1s can deliver value to patients. But the fact that GLP-1s aren't cost-effective at their current net prices can limit ...

Another pressing concern for participants was the rise in drug costs, with 54% expecting at least half of U.S. states to establish drug-affordability boards. Additionally, 97% foresee a 25% surge in ...

Warning that the state’s health care system is “falling apart,” the Senate’s point person on the topic said that she wants to ...

Nicole Stallings, President and CEO of the Hospital and Healthsystem Association of Pennsylvania, discusses how hospitals aim to protect Medicaid from cuts.

Health misinformation has proliferated since the Covid-19 pandemic. How can you spot it and protect yourself? A scientist who ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

For the percentage of people living in pharmacy deserts in the five states that the researchers identified as having the ...

After closing at least six local drugstores in 2024, Walgreens is shutting down an additional Sacramento-area location.

In today's Pharmalittle roundup, we're reading about Medicare negotiations, U.K. drug rebates rising, and more.